| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |